Skip to content

Matrix Laboratories

In liquidation since 13-12-2010 Private limited companyfounded 2005Terhulpsesteenweg 6, 1560 HoeilaartKBO/BCE: BE 0874.864.378 subsidiary of

Last board

1 office holder, 1 auditor, last change in July 2026

Deed of 02-07-2026 resigns as statutory auditor reappointed as statutory auditor · General meeting of 18-06-2026

Statutory auditor, permanent representative
appointed by deed of 25-09-2009 3-year term from 2026
Liquidator
appointed by deed of 04-03-2019 term without a fixed end
Signing authorityThe articles say who may bind the company, for example by signing a contract.
Each director alone
deed of 06-02-2024

Office holders in the KBO →

Mandates through the years

1 name, the dashed line is today

Statutory auditor
Rest of the term
Mandates as a list
    • Statutory auditor, appointed by deed of 25-09-2009, still in office
With Starter you also see 8 former office holders in the mandate history. See the plans →

See the board, name and registered office on a given date →

Control

Consolidating parent
US
consolidates
This company
Matrix Laboratories
Equity -€16.2m
Loss €27,627 in 2025

and 2 other shareholders

Capital

Contribution
€141,033,023.74
Shares
264,500
Contribution per share
€533
Equity per share
-€61.24 in 2025
Source
2025 annual accounts

Owners through the years

as the annual accounts name them
60%
40%
consolidates until 2020
consolidates until 2019
consolidates until 2014
consolidates until 2008
Owners as a list

Source: shareholder structure in its own accounts, parent in its own accounts

Articles of association

deed of 06-02-2024 (in Dutch)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Third Thursday of June at 18:00

Shareholders

3 owners

Owners 3

Capital transactions

Shareholders according to the deeds
Stated in the deed deed of 22-02-2010 ↗
  • 1 share
  • 158,700,000 shares
Capital over time
  1. 06-02-2024 Converted to available equity
  2. 14-12-2010 Capital reduction of €700,000 · to €141,033,023.74 · repaid to the shareholders
  3. 22-02-2010 Capital stated in the deed · €141,733,023.74 · 264,500,000 shares
  4. 18-01-2010 Capital reduction of €47,610,277 · to €58,189,723
  5. 18-01-2010 Capital increase of €87,285,000 · to €145,474,723 · 158,700,000 new shares · in kind
  6. 18-01-2010 Capital increase of €35,029,000 · to €180,503,723 · no new shares · “omzetting in kapitaal van bedrag afgenomen van rekening Uitgiftepremies”
  7. 18-01-2010 Capital reduction of €38,770,699.26 · to €141,733,023.74 · to absorb losses